The 2022 Trauma Webinar Series: Part Five Organ Donation

Dartmouth Health Continuing Education for Professionals Home, The 2022 Trauma Webinar Series: Part Five – Organ Donation, 8/4/2022 12:00:00 PM - 8/4/2025 1:00:00 PM,

This presentation will provide an overview of the collaborative approach process imperative to assuring all families can be informed of their loved ones’ opportunity to save lives through organ and tissue donation if they are deemed medically eligible by the organ procurement organization (OPO). Attendees will also be provided with information and clinical cues to make a timely referral to the OPO.  A broad overview of the clinical management and organ recovery process will also be integrated into this presentation. 

Presenter
Craig Tucker, BS, RRT-NPS, CPTC

About our Presenter
Craig Tucker, BS, RRT-NPS, CPTC has 9+ years of experience working in the Organ Procurement field in both a clinical capacity and leadership capacity.  Currently, Craig oversees Hospital Development and Relations as Director of Donation Strategy for New England Donor Services. Before entering this position he served as a regional director for the Southeastern Region, overseeing both clinical and hospital development coordinators and acting as clinical director and administrator on-call.  Early in Craig’s career at NEDS he spent 3 years as a clinical coordinator managing and facilitating the clinical aspect of the donation process.

Learning Outcome
At the conclusion of this learning activity, (at least 75% of) participants will be able to discuss best practice when providing information and care to families regarding organ donation. 

Disclosure
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported NO financial relationship(s)* with ineligible companies**.

* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).

** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Bibliographic Material

1. NEJM Dec 2004 “Care of the Potential Organ Donor"
2. United Network of Organ Sharing (www.UNOS.org)
3. www.transmedics.com